Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDEA.L Regulatory News (IDEA)

  • There is currently no data for IDEA

Director Dealing

13 Dec 2017 10:18

RNS Number : 2243Z
Ideagen PLC
13 December 2017
 

Ideagen PLC

("Ideagen," "the Company" or the "Group'')

Purchase of shares by director

Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that Alan Carroll, a non-executive director, yesterday purchased 21 ordinary shares in the Company at a price of 104.15 pence each as a result of the automatic reinvestment of the Company's recent dividend.

Following the purchase, Mr Carroll's beneficial interest has increased to 204,021 shares representing approximately 0.1% of the Company's issued share capital.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

Enquiries:

Ideagen plc

01629 699100

David Hornsby, Chief Executive

 

Graeme Spenceley, Finance Director

 

 

 

finnCap Limited

020 7220 0500

Stuart Andrews/Henrik Persson/James Thompson (Nomad)

 

Stephen Norcross (Corporate Broking)

 

 

 

 

 

 About Ideagen plc

Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).

Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.

The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.

For further information please visit www.ideagen.com

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alan Carroll

2.

Reason for the Notification

a)

Position/status

Non-executive director

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ideagen plc

b)

LEI

213800KS1MLITOVNYC85

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B0CM0C50

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

104.15p

21

d)

Aggregated information:

· Aggregated volume

· Price

 

21 ordinary shares of 1p each purchased at 104.15p per share

e)

Date of the transaction

12th December 2017

f)

Place of the transaction

London Stock Exchange AIM market (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMMMMZGFNGNZM
Date   Source Headline
25th May 20224:10 pmRNSHolding(s) in Company
25th May 20223:20 pmRNSForm 8.3 - Ideagen plc
25th May 20223:15 pmBUSForm 8.3 - Ideagen plc
25th May 20222:58 pmRNSForm 8.5 (EPT/RI) - Amendment
25th May 20221:47 pmRNSForm 8.3 - Ideagen plc
25th May 20221:42 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Ideagen plc
25th May 202212:53 pmRNSForm 8.3 - Ideagen plc
25th May 202211:42 amRNSForm 8.5 (EPT/RI)
25th May 202211:13 amRNSForm 8.5 (EPT/RI)
25th May 202210:30 amRNSHolding(s) in Company
25th May 202210:21 amGNWForm 8.3 - Ideagen PLC
25th May 20228:58 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
24th May 20223:15 pmBUSForm 8.3 - Ideagen plc
24th May 20223:00 pmBUSForm 8.3 - Ideagen plc
24th May 20221:45 pmRNSForm 8.3 - Ideagen plc
24th May 20221:03 pmGNWForm 8.3 - Ideagen PLC
24th May 202212:52 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Ideagen plc
24th May 202212:35 pmGNWForm 8.3 - Ideagen Plc
24th May 202211:41 amGNWForm 8.3 - Ideagen
24th May 202211:33 amBUSForm 8.3 - Ideagen Plc
24th May 202211:08 amRNSForm 8.5 (EPT/RI)
24th May 20228:47 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
23rd May 20223:43 pmRNSForm 8.3 - Ideagen plc
23rd May 20223:20 pmRNSForm 8.3 - Ideagen plc
23rd May 20223:15 pmRNSForm 8.3 - Ideagen Plc
23rd May 20223:15 pmBUSForm 8.3 - Ideagen plc
23rd May 20223:07 pmRNSForm 8.3 - IDEAGEN PLC
23rd May 20223:00 pmBUSForm 8.3 - Ideagen plc
23rd May 20222:29 pmGNWForm 8.3 - [IDEAGEN PLC - 20 05 2022] - HHL
23rd May 20221:59 pmGNWForm 8.3 - Ideagen PLC
23rd May 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
23rd May 20221:00 pmRNSHolding(s) in Company
23rd May 202212:43 pmRNSForm 8.3 - Ideagen plc
23rd May 202211:38 amGNWForm 8.3 - Ideagen Plc
23rd May 202211:37 amEQSForm 8.3 - Maitland Institutional Services Limited: Re Ideagen plc
23rd May 202211:20 amGNWForm 8.3 - Ideagen PLC
23rd May 202210:31 amRNSForm 8.5 (EPT/RI)
23rd May 202210:23 amRNSForm 8.5 (EPT/RI)
23rd May 20228:59 amRNSForm 8.5 (EPT/RI) - Ideagen Plc
23rd May 20227:00 amBUSForm 8.3 - Ideagen PLC
20th May 20223:30 pmRNSForm 8.3 - IDEA LN
20th May 20223:27 pmBUSForm 8.3 - Ideagen plc
20th May 20223:20 pmRNSForm 8.3 - Ideagen plc
20th May 20223:01 pmRNSForm 8.3 - IDEAGEN PLC
20th May 20222:54 pmRNSForm 8.5 (EPT/RI)-Replacement of Ideagen plc
20th May 20221:54 pmRNSForm 8.3 - Ideagen Plc
20th May 20221:30 pmBUSForm 8.3 - IDEAGEN PLC
20th May 202212:56 pmGNWForm 8.3 - [IDEAGEN PLC - 19 05 2022] - HHL
20th May 202212:44 pmRNSForm 8.3 - Ideagen plc
20th May 202212:08 pmGNWForm 8.3 - Ideagen PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.